
Robert Schwartz MD
Hepatology & Liver Transplantation
Gastroenterology/Hepatology Fellow
Request Appointment
1283 York AvenueNew York, NY 10021
Overview of Dr. Schwartz
Dr. Robert Schwartz is a gastroenterologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Weill Cornell. He received his medical degree from University of Minnesota Medical School and has been in practice 11 years. He specializes in hepatology & liver transplantation and is experienced in hepatology, viral hepatitides, hepatic cirrhosis, transplant hepatology, and biliary tract disease.
Education & Training
- Mass General Brigham/Brigham and Women's HospitalFellowship, Gastroenterology, 2008 - 2013
- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2006 - 2008
- University of Minnesota Medical SchoolClass of 2006
Certifications & Licensure
- NY State Medical License 2013 - 2027
- MA State Medical License 2009 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Publications & Presentations
PubMed
- 3 citationsImprovement in obesity-related comorbidities 5 years after endoscopic sleeve gastroplasty: a prospective cohort study.Ali Lahooti, Donevan Westerveld, Kate Johnson, Chino Aneke-Nash, Muhammad Usman Baig
Gastrointestinal Endoscopy. 2025-07-01 - Comparing Weight Loss and Metabolic Outcomes of Virtual Versus In-Person Follow-Up Care in Bariatrics: A Propensity-Matched Analysis at 12 and 36 Months Post-ESG.Ali Lahooti, Kate E Johnson, Chino Aneke-Nash, Qusai Al Zureikat, Muhammad U Baig
Obesity Surgery. 2025-06-10 - 5 citationsA nucleosome switch primes hepatitis B virus infection.Nicholas A Prescott, Tracy Biaco, Andrés Mansisidor, Yaron Bram, Justin Rendleman
Cell. 2025-04-17
Press Mentions
- Medical Bulletin 24/ February/ 2025 - VideoFebruary 23rd, 2025
- Digging into a Decades-Old Hepatitis B Mystery Suggests a New Potential TreatmentFebruary 21st, 2025
- HBV’s Ability to Infect Human Liver Cells Thwarted by Potential Anticancer DrugFebruary 20th, 2025
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: